Study Stopped
PI departure from university
Long-term Consumption of Resistant Starch Type-4 (RS4)
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The primary objective of the current proposal is to determine the effectiveness of long-term consumption of Fibersym® RW for improving blood lipids (including cholesterol) and body composition. The overall goal of this clinical research is to determine the potential effects that RS4 consumption may have on the prevention of obesity and obesity-related diseases. Fiber in the form of RS4 will be used for the proposed study, given that fiber has been shown to have many beneficial effects on modifiable risk factors associated with obesity-related diseases. Using a long-term randomized-controlled intervention design, blood lipids (total cholesterol, LDL-c, HDL-c, triglycerides) and body composition will be assessed. The investigators anticipate reductions in cholesterol and body fat percentage following 8-weeks of Fibersym® RW consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2020
CompletedStudy Start
First participant enrolled
February 18, 2020
CompletedFirst Posted
Study publicly available on registry
February 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedOctober 4, 2023
October 1, 2023
3.4 years
February 18, 2020
October 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in plasma lipids
Total cholesterol (TC), LDL-c , VLDL-c, HDL-c , triglycerides (TG) from blood sample in a fasted state
Week 0, 4, and 8
Secondary Outcomes (3)
Change in body composition
Week 0, 4, and 8
Change in BMI
Week 0, 4, and 8
Change in homeostatic model assessment for insulin resistance (HOMA-IR)
Week 0,4, and 8
Study Arms (2)
Resistant starch bar
EXPERIMENTALThe RS4 group will consume one nutrition bar per day formulated using Fibersym® RW.
Native wheat bar
ACTIVE COMPARATORThe control group will consume one native wheat starch bar per day.
Interventions
The RS4 group will consume one nutrition bar per day formulated using Fibersym® RW containing 20g fiber.
The control group will consume one native wheat starch bar per day.
Eligibility Criteria
You may qualify if:
- BMI ≥ 23 kg/m2
- elevated to borderline-high LDL-cholesterol (116-159 mg/dL)
You may not qualify if:
- known allergy to wheat or gluten
- currently taking medication for chronic disease including anti-inflammatory, anti-hypertensive, lipid lowering, glucose controlling, or steroidal medications
- taking any supplements that may affect metabolism
- having anemia or a history of anemia
- current smoker or a user in the past three months
- currently pregnant or lactating/planning to become pregnant during the intervention
- having elevated blood pressure (≥130mmHg/≥80mmHg)
- presence of diagnosed diabetes mellitus, inflammatory disease, atherosclerotic disease, or other relevant chronic conditions that may affect metabolic processes
- total cholesterol ≥ 240mg/dL.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kansas State Universitylead
- MGP Ingredients, Inc.collaborator
Study Sites (1)
Physical Activity and Nutrition Clinical Research Consortium
Manhattan, Kansas, 66502, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Rosenkranz, PhD
Kansas State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The participant will be blind to the condition that they are in.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 18, 2020
First Posted
February 20, 2020
Study Start
February 18, 2020
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
October 4, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share